ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NRSNW NeuroSense Therapeutics Ltd

0.13
0.00 (0.00%)
Pre Market
Last Updated: 20:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -3.26M-3.59M-7.71M-3.38M-3.64M-3.48M-6.75M-3.29M
Pre Tax Income -2.72M-3.48M-2.99M-3.15M-3.89M-5.23M784k-2.95M
Net Income -2.72M-3.48M-2.99M-3.15M-3.89M-5.23M784k-2.95M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -3.26M-3.59M-7.71M-3.38M-3.64M-3.48M-6.75M-3.29M
EBITDA -3.26M-3.55M-7.75M-3.37M-3.64M-3.43M-6.8M-3.19M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -1.24M-2.89M-5.59M-13.55M-13.3M
Pre Tax Income -1.22M-2.83M-4.04M-12.34M-11.28M
Net Income -1.22M-2.83M-4.04M-12.34M-11.28M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -0.71-1.52-0.369-1.047-0.733
EBIT -1.24M-2.89M-5.59M-13.55M-13.3M
EBITDA -1.24M-2.89M-5.58M-13.54M-13.21M